X

Glenmark Pharmaceuticals Ltd Q2FY25; 13% rise in Profits

Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries.

Financial Results:

Godrej Consumer Products Ltd reported Revenues for Q2FY25 of ₹3,666.00 Crores up from ₹3,602.00 Crore year on year, a rise of 1.78%.

Total Expenses for Q2FY25 of ₹3,040.00 Crores up from ₹3,036.00 Crores year on year, a rise of 0.13%.

Consolidated Net Profit of ₹491.00 Crores up 13.39% from ₹433.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹4.80, up 13.48% from ₹4.23 in the same quarter of the previous year.

Related Post